Canadian Ruling Puts Seroquel Suits In Limbo

Law360, New York (May 11, 2012, 4:20 PM EDT) -- A Canadian court has refused to certify a class of users of antipsychotic treatment Seroquel who claim AstraZeneca Pharmaceuticals PLC misled consumers about the safety of the drug, striking a significant north-of-the-border blow on May 7 to litigation that is all but resolved in the U.S.

Judge Carolyn J. Horkins not only denied the plaintiffs' bid for class certification, she blasted the adequacy of their allegations. The suit lumps AstraZeneca and various related entities named as defendants into a single group and offers confusing and inconsistent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.